Trial Profile
Single-dose, Open-label, Randomized, 2-way Crossover Bioequivalence Study of 10 mg Granules for Oral Suspension Rivaroxaban Versus 10 mg Tablets Rivaroxaban Under Fasted Condition in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Rivaroxaban
- Indications Thromboembolism; Venous thrombosis
- Focus Pharmacokinetics
- Sponsors Bayer
- 09 Nov 2017 Status changed from recruiting to completed.
- 28 Jun 2017 New trial record